In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Se og Hor reported a sighting of the royal boarding a flight from Gardermoen to London at 1pm with Marius Borg Høiby, 27, who ...

Q3 2024 Earnings Call Transcript November 7, 2024 MannKind Corporation beats earnings expectations. Reported EPS is $0.05, ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsMichael Castagna - CEOChris Prentiss ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...

They naturally shorten over time and are therefore involved in many biological ... such as Dyskeratosis Congenita, bone ...

reversing the 180 mL decline over that period that would typically be observed in untreated IPF patients. The drug – taken orally twice a day – was also safe and well-tolerated over 36 weeks ...

MannKind will host a conference call and presentation webcast to discuss these results today at 4:30 p.m. Eastern Time. The webcast will be accessible via a link on MannKind’s website. A replay will ...

Securities and Exchange Commission is introducing an express prohibition of Ponzi/Pyramid schemes and other illegal ...

Don Bosseler, an All-American fullback who led Miami to the No. 6 ranking in The Associated Press poll in 1956 and was ...

As we know IPF is a growing therapeutic area with over $4.2 billion ... you can see your A one C continue to improve over time. We also continue to see more people getting the goal of almost 42% got ...

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...